Beta Bionics, Inc. BBNX
NASDAQ
| 09/30/2026 | 06/30/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 10.91% | 15.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.91% | 15.88% | |||
| Cost of Revenue | 15.73% | 17.18% | |||
| Gross Profit | 7.56% | 15.00% | |||
| SG&A Expenses | 2.12% | 12.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.85% | 10.97% | |||
| Operating Income | -4.03% | -5.39% | |||
| Income Before Tax | -4.06% | -6.89% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.06% | -6.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.06% | -6.89% | |||
| EBIT | -4.03% | -5.39% | |||
| EBITDA | -3.41% | -4.99% | |||
| EPS Basic | 0.42% | -6.64% | |||
| Normalized Basic EPS | 0.43% | -6.62% | |||
| EPS Diluted | 0.42% | -6.64% | |||
| Normalized Diluted EPS | 0.43% | -6.62% | |||
| Average Basic Shares Outstanding | 4.48% | 0.25% | |||
| Average Diluted Shares Outstanding | 4.48% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||